In silico criteria for tumor selection may include the presence of GM-CSF, IL-3 and FLT3-L, ligand expression of chemokine receptors CXCR4, CCR7, and CXCR3 and the absence of very high GM-CSF level. This evidence concerns the gene CSF2 and neoplasm.